Abstract BackgroundDefine the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, randomized, double-masked, placebo-controlled clinical study. MethodsEyes (1000) were randomized to placebo (497) or nepafenac 0.3% (503) used once daily, post-operatively for 5Â weeks at two ophthalmology clinics. Diagnosis of PCME was made by clinical, ocular coherence tomography (OCT), and with fluorescein angiography confirmation. Correlation of PCME to NSAID use and the presence of pre-operative risk factors for PCME were assessed including, contralateral PCME, diabetic retinopathy, retinal vein occlusion, macular hole, epiretinal membrane, macular degeneration, retinal detachment repair, and prostaglandin use. ResultsPCME was the most common complication associated with routine cataract surgery (4.2% with PCME risk factors, 2.0% with risk factors excluded). Topical nepafenac 0.3% significantly reduces the incidence of PCME compared to placebo when used after routine cataract surgery (p = .0001). When patients with pre-operative risk factors are excluded, the incidence of PCME between treatment and placebo groups is equivalent (p = 0.31). PCME relative risk (RR) was most significant in contralateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane (RR 5.7). Prostaglandin use and previous retinal detachment were not shown to increase risk. ConclusionPseudophakic cystoid macular edema is common after phacoemulsification cataract surgery. Topical nepafenac 0.3% reduces PCME in patients with pre-operative risk factors for PCME compared to placebo but shows no benefit in patients without pre-operative risk factors. Trial registrationNIH ClincalTrials.gov retrospectively registered January 15, 2017, NCT03025945.
incidence           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

Prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

coherence                     0.9999256277521702^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Coherence_(physics)   

ocular                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_eye             

OCT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optical_coherence_tomography

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

clinical study                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

contralateral                 0.9999999958254193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

relative risk                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

non-steroidal anti-inflammatory drug1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

macular degeneration          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

pseudophakic                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intraocular_lens      

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

ophthalmology                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ophthalmology         

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

fluorescein angiography       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescein_angiography

contralateral                 0.9999999958254193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

risk factors                  0.637981235405108^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stroke                

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

topical steroid               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_steroid       

tomography                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

placebo-controlled            0.9999998922876387^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

